Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.27USD
2:30pm GMT
Change (% chg)

$0.01 (+0.31%)
Prev Close
$3.26
Open
$3.24
Day's High
$3.28
Day's Low
$3.24
Volume
39,406
Avg. Vol
548,892
52-wk High
$5.05
52-wk Low
$1.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.38 -0.208
Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 5 0.53 1.10 0.20 --
Quarter Ending Jun-19 5 1.48 2.30 0.70 --
Year Ending Dec-19 9 8.05 13.30 4.70 12.40
Earnings (per share)
Quarter Ending Mar-19 5 -0.24 -0.20 -0.27 --
Quarter Ending Jun-19 5 -0.24 -0.18 -0.30 --
Year Ending Dec-19 9 -0.94 -0.71 -1.24 -0.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 3.03 1.08 0.90
Price to Sales (TTM) 14.87 49.51 6.29
Price to Book (MRQ) -- 10.14 5.26
Price to Tangible Book (MRQ) -- 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 39.70 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 206.16 12.76
Sales (TTM) vs TTM 1 Yr. Ago -37.00 48.79 5.84
Sales - 5 Yr. Growth Rate 74.52 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate 13.00 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 2.24 2.25
Current Ratio (MRQ) 4.92 3.50 3.08
LT Debt to Equity (MRQ) -- 18.65 11.38
Total Debt to Equity (MRQ) -- 31.33 16.12
Interest Coverage (TTM) -1.82 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -110.41 12.87
Operating Margin (TTM) -238.47 -184.63 6.19
Operating Margin - 5 Yr. Avg. -170.81 -126.89 8.31
Pre-Tax Margin (TTM) -319.40 -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -212.89 -132.69 8.61
Net Profit Margin (TTM) -319.19 -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -213.88 -137.08 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 7,654,547 842,388,263
Net Income/Employee (TTM) -1,274,205 562,105 99,841,601
Receivable Turnover (TTM) 4.98 6.23 5.71
Inventory Turnover (TTM) 9.22 1.89 3.47
Asset Turnover (TTM) 0.16 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 6.39 11.06
Return on Assets - 5 Yr. Avg. -34.34 5.47 12.20
Return on Investment (TTM) -63.23 8.92 14.45
Return on Investment - 5 Yr. Avg. -39.19 6.78 15.87
Return on Equity (TTM) -- 10.08 15.96
Return on Equity - 5 Yr. Avg. -81.78 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 54.55 49.22 95 99
13 Week 142.86 131.03 98 95
26 Week 85.45 71.36 90 98
52 Week 35.64 14.96 72 72
YTD 96.15 72.26 85 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.48%
# of Holders: 80
Total Shares Held: 15,258,437
3 Mo. Net Change: 7,572,311
# New Positions: 29
# Closed Positions: 19
# Increased Positions: 53
# Reduced Positions: 32
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.